Emergent BioSolutions (EBS) Change in Inventory (2010 - 2026)

Emergent BioSolutions' Change in Inventory history runs 17 years deep, the most recent figure standing at -$15.8 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 818.18% year-over-year to -$15.8 million; the TTM figure through Mar 2026 stood at $12.3 million (down 44.59% YoY), while the FY2025 annual figure was $30.3 million, up 23.67% from the prior year.
• Change in Inventory was -$15.8 million for Q1 2026 at Emergent BioSolutions, down from -$14.2 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $50.1 million in Q1 2022 to a low of -$127.7 million in Q4 2022.
• Historically, Change in Inventory has averaged $794117.6 across 5 years, with a median of $4.5 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Change in Inventory slumped 1584.88% in 2022, then surged 17900.0% in 2024.
• A 5-year view of Change in Inventory shows it stood at -$127.7 million in 2022, then soared by 79.95% to -$25.6 million in 2023, then jumped by 57.03% to -$11.0 million in 2024, then dropped by 29.09% to -$14.2 million in 2025, then decreased by 11.27% to -$15.8 million in 2026.
• The last three Change in Inventory figures came in at -$15.8 million (Q1 2026), -$14.2 million (Q4 2025), and $17.6 million (Q3 2025), per Business Quant data.